Cargando…
Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
We performed this retrospective clinical study to examine the prognostic power of bone scintigraphy (BS) and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in terms of overall survival (OS) of breast cancer with bone-only metastasis. We retrospectively evaluat...
Autores principales: | Park, Soyeon, Yoon, Joon-Kee, Jin Lee, Su, Kang, Seok Yun, Yim, Hyunee, An, Young-Sil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815705/ https://www.ncbi.nlm.nih.gov/pubmed/29390293 http://dx.doi.org/10.1097/MD.0000000000008985 |
Ejemplares similares
-
Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer
por: Al-Muqbel, Kusai M., et al.
Publicado: (2016) -
Volume-based metabolic parameter of breast cancer on preoperative (18)F-FDG PET/CT could predict axillary lymph node metastasis
por: An, Young-Sil, et al.
Publicado: (2017) -
Clinicopathologic features of single bone metastasis in breast cancer
por: Karatas, Murat, et al.
Publicado: (2021) -
Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer
por: Lim, Chae Hong, et al.
Publicado: (2016) -
Anemia and thrombocytopenia as initial symptoms of occult breast cancer with bone marrow metastasis: A case report
por: Liu, Lulu, et al.
Publicado: (2017)